Modified FOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab beyond first progression in advanced colorectal cancer: CCOG-0801 study. A phase I/II study of biweekly XELIRI plus bevacizumab ...
For example, if a patient has ulcerative colitis or Crohn's disease that is not well controlled with medication, or if a colonoscopy shows precancerous lesions, a doctor may recommend a total or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results